Blueprint Medicines Appoints Percy Carter, MBA, Ph.D., as Chief Scientific Officer
"I am thrilled to welcome Percy to
"It is a great privilege to join
About
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding expectations related to
Trademarks
View original content to download multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-appoints-percy-carter-mba-phd-as-chief-scientific-officer-301291311.html
SOURCE
Media: Andrew Law, 617-844-8205, media@blueprintmedicines.com, Investor Relations Contact: Kristin Hodous, 617-714-6674, ir@blueprintmedicines.com